Some researchers found, that CXCL8 is a potential biomarker of tumor burden and aggressiveness, not only in HCC, but also other types of tumors (i.e., melanoma, renal cell carcinoma and non-small-cell lung cancer [85,86,87]. The gene discussed is CXCL8; the disease is neoplasm.